[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-the-goldman-sachs-group-has-lo3301963feb-d73f-760a-b24f-815c13ee2570":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":10,"showTags":10,"source":11,"reactions":12,"selfReactions":13,"logo":14,"sourceId":15,"sourceUserId":16,"asset":17,"tagsCategories":18,"totalComments":19,"lang":20,"unique_views_count":21,"enrichStatus":17,"triageKind":16,"triageImportance":16,"expandEligible":16,"summarizeEligible":16,"eventEligible":16,"eventType":16,"eventAction":16},"the-goldman-sachs-group-has-lo3301963feb-d73f-760a-b24f-815c13ee2570","1744827848000","The Goldman Sachs Group Has Lowered Expectations for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price","The Goldman Sachs Group lowered their price target on shares of Regeneron Pharmaceuticals from $1,019.00 to $917.00 and set a \"buy\" rating on the stock in a report on Monday.","https://www.marketbeat.com/instant-alerts/the-goldman-sachs-group-has-lowered-expectations-for-regeneron-pharmaceuticals-nasdaqregn-stock-price-2025-04-14/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","1"]